Mesenchymal stem cells obtained from Wharton's jelly for the treatment of sepsis

The invention relates to human mesenchymal stem cells obtained from Wharton's jelly, a process for the preparation thereof, and the therapeutic uses thereof, in particular for the treatment of sepsis.

Saved in:
Bibliographic Details
Main Authors Bensoussan, Danièle, Boufenzer, Amir, Gibot, Sébastien, Reppel, Loïc, Avercenc, Léonore, Huselstein, Céline, Laroye, Caroline
Format Patent
LanguageEnglish
Published 01.08.2024
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:The invention relates to human mesenchymal stem cells obtained from Wharton's jelly, a process for the preparation thereof, and the therapeutic uses thereof, in particular for the treatment of sepsis.
Bibliography:Application Number: AU20180228352